Toggle Main Menu Toggle Search

Open Access padlockePrints

Vibrotactile positional therapy for the treatment of positional obstructive sleep apnoea: a multicentre, randomised controlled trial

Lookup NU author(s): Dr Sophie West

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© Author(s) (or their employer(s)) 2025. No commercial re-use. See rights and permissions. Published by BMJ Group. Background: New generation positional therapy devices provide vibrotactile feedback to patients with positional obstructive sleep apnoea (POSA), reducing supine sleep time and sleep apnoea severity. Longer-term effects on POSA severity, sleepiness and quality of life (QoL) are unclear. Methods: A randomised, parallel, double-blinded trial compared neck-worn positional therapy with sham-positional therapy over 3 months (ClinicalTrials.gov: NCT04153240). Adult patients with POSA (apnoea/hypopnoea index (AHI) >5 events/hour, 2:1 when supine vs non-supine) were randomised (1:1). The primary endpoint was AHI at 3 months, positional versus sham. Secondary analyses: interaction between the treatment effect and age; QoL, including Epworth Sleepiness Scale (ESS) and Pittsburgh Sleep Quality Index (PSQI). Results: Between October 2019 and August 2022, 120 patients with median baseline AHI of 12.8 events/ hour (IQR 9.2–18.5) were randomised; 59 to positional therapy and 61 to sham; 92 (77%) completed the trial. Positional therapy significantly reduced the AHI by −4.41 events/hour (95% CI −7.77 to –1.06; p=0.011) compared with sham, a 34% improvement. There was a significant improvement in PSQI: −1.0 (95% CI −2.1 to 0.0; p=0.04), but not ESS: −0.6 (95% CI −1.8 to 0.6; p=0.3), with positional therapy compared with sham (baseline ESS 8.8). Similar results were seen in younger (18–64) and older (≥65) age groups. Patients’ bed partners reported improvements in snoring and sleep quality for the patient and themselves. Over half of participants using the active device opted to continue. Conclusion: Neck-worn positional therapy reduced the severity of OSA and improved sleep quality but not sleepiness, over 3 months. Bed partner’s reported improvements in snoring and sleep quality.


Publication metadata

Author(s): Kelly JL, Turnbull CD, Newson R, Dobson M, ALQarni AS, Nevinson A, Dawson D, Nickol A, West S, Talbot NP, Rahman NM, Stradling J, Morrell MJ, on behalf of the POSA trial investigators

Publication type: Article

Publication status: Published

Journal: Thorax

Year: 2025

Pages: Epub ahead of print

Online publication date: 24/09/2025

Acceptance date: 11/08/2025

ISSN (print): 0040-6376

ISSN (electronic): 1468-3296

Publisher: BMJ Publishing Group

URL: https://doi.org/10.1136/thorax-2024-222681

DOI: 10.1136/thorax-2024-222681

PubMed id: 40992934


Altmetrics

Altmetrics provided by Altmetric


Share